Patents by Inventor Jun Chung

Jun Chung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190298784
    Abstract: The present invention relates to a novel Bifidobacterium strain having an excellent growth promoting effect, and a nutraceutical composition for promotion of growth, which contains the strain. The strain of the present invention has a beneficial effect of promoting growth by promoting the digestion of human milk oligosaccharides to enhance immunity together with physical strength.
    Type: Application
    Filed: April 12, 2019
    Publication date: October 3, 2019
    Inventor: Myung Jun CHUNG
  • Publication number: 20190256934
    Abstract: The present invention a Bifidobacterium longum CBT BG7 Bifidobacterium, which has an excellent growth promoting effect and was internationally deposited with the Korean Collection for Type Culture (KCTC) of the Korea Research Institute of Bioscience and Biotechnology under accession number KCTC 12200BP. The strain of the present invention has a beneficial effect of promoting growth by promoting the digestion of human milk oligosaccharides to enhance immunity together with physical strength.
    Type: Application
    Filed: April 4, 2019
    Publication date: August 22, 2019
    Inventor: Myung Jun CHUNG
  • Publication number: 20190201481
    Abstract: The present invention relates to a protein derived from lactic acid bacteria and a method for producing the same. The lactic acid bacteria-derived protein of the present invention is a purified protein isolated from lactic acid bacteria (Lactobacillus rhamnosus) having an excellent therapeutic effect against colorectal cancer. It has been demonstrated to have a remarkable effect against colorectal diseases, and thus is expected to be widely used as a natural protein therapeutic agent against colorectal diseases in the medical field.
    Type: Application
    Filed: February 15, 2017
    Publication date: July 4, 2019
    Applicant: CELL BIOTECH CO., LTD.
    Inventor: Myung Jun CHUNG
  • Publication number: 20190027445
    Abstract: A system in package (SiP) is disclosed that uses an EMI shield to inhibit EMI or other electrical interference on the components within the SiP. A metal shield may be formed on an upper surface of an encapsulant encapsulating the SiP. The metal shield may be electrically coupled to a ground layer in a printed circuit board (PCB) to form the EMI shield around the SiP. The metal shield may be electrically coupled to the ground layer using one or more conductive structures located in the encapsulant. The conductive structures may be located on a perimeter of the components in the SiP. The conductive structures may provide a substantially vertical connection between the substrate and the shield on the upper surface of the encapsulant.
    Type: Application
    Filed: September 26, 2018
    Publication date: January 24, 2019
    Inventors: Meng Chi Lee, Shakti S. Chauhan, Flynn P. Carson, Jun Chung Hsu, Tha-An Lin
  • Publication number: 20180333441
    Abstract: The present invention relates to a composition for alcohol or acetaldehyde degradation, which comprises probiotics. The composition of the present invention has a significant synergistic effect on the degradation of alcohol or acetaldehyde, when the probiotics are administered alone or in combination or the composition further comprises excipients. In addition, the composition according to the present invention may effectively degrade alcohol and acetaldehyde, thereby not only treating or preventing alcohol-induced diseases, but also effectively relieving hangovers caused by excessive drinking.
    Type: Application
    Filed: May 10, 2018
    Publication date: November 22, 2018
    Inventor: Myung Jun CHUNG
  • Patent number: 10115677
    Abstract: A system in package (SiP) is disclosed that uses an EMI shield to inhibit EMI or other electrical interference on the components within the SiP. A metal shield may be formed on an upper surface of an encapsulant encapsulating the SiP. The metal shield may be electrically coupled to a ground layer in a printed circuit board (PCB) to form the EMI shield around the SiP. The metal shield may be electrically coupled to the ground layer using one or more conductive structures located in the encapsulant. The conductive structures may be located on a perimeter of the components in the SiP. The conductive structures may provide a substantially vertical connection between the substrate and the shield on the upper surface of the encapsulant.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: October 30, 2018
    Assignee: Apple Inc.
    Inventors: Meng Chi Lee, Shakti S. Chauhan, Flynn P. Carson, Jun Chung Hsu, Tha-An Lin
  • Patent number: 10109593
    Abstract: A system in package (SiP) is disclosed that uses an EMI shield to inhibit EMI or other electrical interference on the components within the SiP. A metal shield may be formed over the SiP. The metal shield may be electrically coupled to a ground layer in a printed circuit board (PCB) to form the EMI shield around the SiP. The substrate of the SiP may include at least some metallization along vertical walls in the end portions of the substrate. The metallization may provide a large contact area for coupling the metal shield to a ground ring coupled to the ground layer in the PCB. The metallization along the vertical walls in the end portions of the substrate may be formed as through-metal vias in a common substrate before singulation to form the SiP.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: October 23, 2018
    Assignee: Apple Inc.
    Inventors: Meng Chi Lee, Shakti S. Chauhan, Flynn P. Carson, Jun Chung Hsu, Tha-An Lin
  • Publication number: 20180179603
    Abstract: The present invention a Bifidobacterium longum CBT BG7 Bifidobacterium, which has an excellent growth promoting effect and was internationally deposited with the Korean Collection for Type Culture (KCTC) of the Korea Research Institute of Bioscience and Biotechnology under accession number KCTC 12200BP. The strain of the present invention has a beneficial effect of promoting growth by promoting the digestion of human milk oligosaccharides to enhance immunity together with physical strength.
    Type: Application
    Filed: July 13, 2015
    Publication date: June 28, 2018
    Inventor: Myung Jun CHUNG
  • Publication number: 20180125901
    Abstract: The present invention relates to a functional composition for preventing, alleviating or treating bone disease and lipid-related metabolic disease, and more particularly to a composition which comprises a combination of probiotics and a vitamin complex, which is capable of effectively preventing, alleviating or treating bone disease, obesity and lipid-related metabolic disease by synergistic effects on antioxidant activity, a reduction in blood lipid levels and the promotion of in vivo absorption of calcium and iron.
    Type: Application
    Filed: November 2, 2017
    Publication date: May 10, 2018
    Inventor: Myung Jun CHUNG
  • Patent number: 9967411
    Abstract: An image forming apparatus is provided. The image forming apparatus includes: a storage configured to store a color conversion table; an image former configured to print a compensation chart corresponding to the color conversion table; a scanner configured to scan the printed compensation chart; and a changer configured to understand a range of brightness that the image former is able to represent using the scanned compensation chart, generate a gamma curve corresponding to the understood range of brightness, and change the color conversion table based on the generated gamma curve.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: May 8, 2018
    Assignee: S-PRINTING SOLUTION CO., LTD.
    Inventors: Woo-jun Chung, Hyun-soo Oh, In-ho Park, Nam-ju Shin, Kyeong-man Kim
  • Publication number: 20180117102
    Abstract: The present invention provides a pharmaceutical composition and a food composition for preventing or treating lipid-related metabolic disease, which contain, as active ingredients, probiotics and a vitamin B complex. When the composition comprising the probiotics and the vitamin B complex is used, it may further promote in vivo absorption of the vitamin B complex, and may induce a synergistic effect on a reduction in blood lipid levels, thereby exhibiting an effect on the alleviation, prevention or treatment of obesity and lipid-related metabolic disease.
    Type: Application
    Filed: November 2, 2017
    Publication date: May 3, 2018
    Inventor: Myung Jun CHUNG
  • Publication number: 20180117103
    Abstract: The present invention provides an antioxidant composition and/or a composition for improving skin conditions, which contain, as active ingredients, probiotics and vitamin C. The composition containing probiotics and vitamin C as active ingredients according to the present invention can exhibit a synergistic effect on the activation of antioxidant enzyme, thereby exhibiting an antioxidant effect and a skin condition improving effect. In addition, the composition containing probiotics and vitamin C as active ingredients according to the present invention can more effectively induce antioxidant effects to activate energy metabolism in vivo, thereby exhibiting a significant synergistic effect on weight loss.
    Type: Application
    Filed: November 2, 2017
    Publication date: May 3, 2018
    Inventor: Myung Jun CHUNG
  • Publication number: 20180087093
    Abstract: The present invention relates to a probe for detecting drug-resistant gram-positive pathogens, a probe set, and a method of detecting drug-resistant gram-positive pathogens using them. The probe for detecting drug-resistant gram-positive pathogens, the probe set, and the method for detecting drug-resistant gram-positive pathogens using them according to the present invention can contribute not only to shortening a detection time, compared to a conventional detection time, by optimizing a hybridization time, but also to increasing the sensitivity of detection by pre-amplification of the specific sequence of drug-resistant gram-positive pathogens, and thereby multiple detections of drug-resistant gram-positive pathogens can be accurately and efficiently performed.
    Type: Application
    Filed: June 8, 2017
    Publication date: March 29, 2018
    Inventors: Yeun Jun CHUNG, Dong Gun LEE, Chul Min PARK, Bo Ram CHUNG
  • Publication number: 20180082858
    Abstract: Method of forming ultra thin coreless substrates are described. In an embodiment, the method utilizes a debond layer including high and low adhesion surface areas to the carrier substrate, and cutting through the low adhesion surface areas to remove a build-up structure from the carrier substrate. An electrical short layer may be formed as a part of or on the debond layer to facilitate electrical testing of the build-up structure prior to debonding, and aid in the formation a “known good” substrate on a support substrate.
    Type: Application
    Filed: November 29, 2017
    Publication date: March 22, 2018
    Inventors: Jun Chung Hsu, Flynn P. Carson, Kwan-Yu Lai
  • Patent number: 9899239
    Abstract: Method of forming ultra thin coreless substrates are described. In an embodiment, the method utilizes a debond layer including high and low adhesion surface areas to the carrier substrate, and cutting through the low adhesion surface areas to remove a build-up structure from the carrier substrate. An electrical short layer may be formed as a part of or on the debond layer to facilitate electrical testing of the build-up structure prior to debonding, and aid in the formation a “known good” substrate on a support substrate.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: February 20, 2018
    Assignee: APPLE INC.
    Inventors: Jun Chung Hsu, Flynn P. Carson, Kwan-Yu Lai
  • Publication number: 20180028580
    Abstract: The present invention relates to a novel Bifidobacterium strain having an excellent growth promoting effect, and a nutraceutical composition for promotion of growth, which contains the strain. The strain of the present invention has a beneficial effect of promoting growth by promoting the digestion of human milk oligosaccharides to enhance immunity together with physical strength.
    Type: Application
    Filed: July 13, 2015
    Publication date: February 1, 2018
    Inventor: Myung Jun CHUNG
  • Publication number: 20170301631
    Abstract: A system in package (SiP) is disclosed that uses an EMI shield to inhibit EMI or other electrical interference on the components within the SiP. A metal shield may be formed on an upper surface of an encapsulant encapsulating the SiP. The metal shield may be electrically coupled to a ground layer in a printed circuit board (PCB) to form the EMI shield around the SiP. The metal shield may be electrically coupled to the ground layer using one or more conductive structures located in the encapsulant. The conductive structures may be located on a perimeter of the components in the SiP. The conductive structures may provide a substantially vertical connection between the substrate and the shield on the upper surface of the encapsulant.
    Type: Application
    Filed: June 22, 2017
    Publication date: October 19, 2017
    Inventors: Meng Chi Lee, Shakti S. Chauhan, Flynn P. Carson, Jun Chung Hsu, Tha-An Lin
  • Patent number: 9721903
    Abstract: A system in package (SiP) is disclosed that uses an EMI shield to inhibit EMI or other electrical interference on the components within the SiP. A metal shield may be formed on an upper surface of an encapsulant encapsulating the SiP. The metal shield may be electrically coupled to a ground layer in a printed circuit board (PCB) to form the EMI shield around the SiP. The metal shield may be electrically coupled to the ground layer using one or more conductive structures located in the encapsulant. The conductive structures may be located on a perimeter of the components in the SiP. The conductive structures may provide a substantially vertical connection between the substrate and the shield on the upper surface of the encapsulant.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: August 1, 2017
    Assignee: Apple Inc.
    Inventors: Meng Chi Lee, Shakti S. Chauhan, Flynn P. Carson, Jun Chung Hsu, Tha-An Lin
  • Publication number: 20170204463
    Abstract: The present invention relates to a method of predicting the risk of developing ankylosing spondylitis using DNA copy number variation. It was verified that the risk of developing ankylosing spondylitis can be effectively predicted using primers for detecting DNA copy number variation, of the present invention, and the sensitivity and specificity of prediction can be improved by grafting the results of single nucleotide polymorphism (SNP) measurements, and thus more fundamental approaches for preventing and treating ankylosing spondylitis are expected.
    Type: Application
    Filed: September 30, 2014
    Publication date: July 20, 2017
    Applicant: Catholic University Industry Academic Cooperation Foundation
    Inventors: Yeun-Jun CHUNG, Tae-Hwan KIM, Seung Cheol SHIM, Seung-Hyun JUNG
  • Patent number: D794265
    Type: Grant
    Filed: October 12, 2015
    Date of Patent: August 8, 2017
    Assignee: LG Electronics Inc.
    Inventors: Wook Jun Chung, Ye Ji Um, Byeong Kook Kim, Jea Seok Seong